Lucie Lanikova
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Hemoglobinopathies and Related Disorders 4
-
- Acute Myeloid Leukemia Research 3
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
- Kruppel-like factors research 3
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Hemoglobinopathies and Related Disorders 4
-
- Erythrocyte Function and Pathophysiology 4
-
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Josef T. PrchalVladimír DivokýFelipe LorenzoJán GurskýMonika HorváthováVladimír KořínekXiaosong HuangMartina Vojtěchová
- Cited by
- GeneticsHematologyCancer Research
- Partner nations
- CzechiaUnited StatesRussia
In The Last Decade
Lucie Lanikova
16 papers receiving 234 citations
Peers
Comparison fields: 5 of 45
- Genetics 70
- Hematology 63
- Cancer Research 60
- Molecular Biology 136
- Genetics 43
Countries citing papers authored by Lucie Lanikova
This map shows the geographic impact of Lucie Lanikova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Lanikova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Lanikova more than expected).
Fields of papers citing papers by Lucie Lanikova
This network shows the impact of papers produced by Lucie Lanikova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Lanikova. The network helps show where Lucie Lanikova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lucie Lanikova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2020 | 21 | |
| 5 | 2020 | 3 | |
| 6 | 2019 | 32 | |
| 7 | 2019 | 7 | |
| 8 | 2019 | 3 | |
| 9 | 2018 | 31 | |
| 10 | 2016 | 5 | |
| 11 | 2016 | 14 | |
| 12 | 2016 | 8 | |
| 13 | 2014 | 23 | |
| 14 | 2013 | 7 | |
| 15 | 2013 | 35 | |
| 16 | 2013 | 27 | |
| 17 | 2013 | 15 |
About Lucie Lanikova
Lucie Lanikova is a scholar working on Genetics, Hematology and Cancer Research, having authored 17 papers that have together received 236 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Erythrocyte Function and Pathophysiology (4 papers), Epigenetics and DNA Methylation (4 papers), Hemoglobinopathies and Related Disorders (4 papers), RNA modifications and cancer (3 papers), Acute Myeloid Leukemia Research (3 papers), Kruppel-like factors research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Genetics (70 citations), Hematology (63 citations) and Cancer Research (60 citations). Lucie Lanikova has collaborated with scholars based in Czechia, United States and Russia. Frequent co-authors include Josef T. Prchal, Vladimír Divoký, Felipe Lorenzo, Ján Gurský, Monika Horváthová, Vladimír Kořínek, Xiaosong Huang, Martina Vojtěchová, Lucie Janečková and Jerry L. Spivak. Their work appears in journals such as Nature Communications, Blood and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.